• HAR Flame
  • HAR Flame
  • HAR Flame
  • HAR Flame
  • HAR Flame
  • HAR Flame
Organization Information
Tony's Protate Cancer Research Foundation
Our mission is to raise funds to support current research of a non-invasive cure for prostate cancer. The Foundation recently received FDA approval for Phase 1B testing using the cancer-suppressing protein which naturally occurs in our bodies. Injec
Visit Website
Volunteer Postings
Martha Turner Sotheby's International Agent Recognized for PhilanthropyWhen volunteer Susan Whitacre was asked why she volunteers for a man's disease she said, " You would be mistaken to believe that cancer of the prostate affects only men. It profoundly affects the loves of the women who love them; the mothers, daughters, wives, sisters and friends. That’s why I’m driven to make sure that women ‘get’ prostate cancer….not contract it, but understand prostate cancer. Offering our time and our talents and our resources to the philanthropic efforts for research for the cure, enriches every one of our individual lives, that of our families and our community as well. It reaches across generations …carrying the promise of a future which is cancer free for our children, it bridges the gender divide…offering information, resources and options to men and hope and support to the women who love them.”At a private dinner recently, real estate agent Susan Whitacre was recognized for her breadth of service and generous philanthropic efforts during the past seven years in support of Tony’s Prostate Cancer Research foundation for the cure. Whitacre’s 4000+ hours of volunteer service raised significant financial support as well as local, national and international awareness of the groundbreaking research and development of the GLIPR1 therapy for the cure of prostate cancer. “It is generous donors and committed volunteers like Susan Whitacre who make it possible that the cure for prostate cancer will be found in my lifetime.” said 77 year old TPCR founder Tony Masraff, who was diagnosed with prostate cancer in 1999. “If it weren’t for the support of the private sector, we would not be celebrating the FDA approval of the development of the GLIPR1 therapy for Phase1B testing on the first group of men.”  (visit www.TPCR.org) “Susan’s creative ideas often challenge us to think outside the box.” continued Masraff. He was referring to her ‘bucking’ th